Baidu
map

Gastroenterology :鱼类脂肪酸或可降低肝癌风险

2012-05-24 爱唯医学网 爱唯医学网

近日,6月刊的《胃肠病学》(Gastroenterology )发表的一项以人口为基础的日本成人研究显示,食用富含n-3多不饱和脂肪酸(n-3 PUFA)的鱼类以及二十碳五烯酸(EPA)、二十二碳五烯酸(DPA)和二十二碳六烯酸(DHA)等n-3 PUFA与肝细胞癌(HCC)发生风险呈剂量依赖性负相关。 长期以来,食用n-3 PUFA被认为可降低多种癌症的发生风险,但对肝癌预防作用的专门研究报道

近日,6月刊的《胃肠病学》(Gastroenterology )发表的一项以人口为基础的日本成人研究显示,食用富含n-3多不饱和脂肪酸(n-3 PUFA)的鱼类以及二十碳五烯酸(EPA)、二十二碳五烯酸(DPA)和二十二碳六烯酸(DHA)等n-3 PUFA与肝细胞癌(HCC)发生风险呈剂量依赖性负相关。

长期以来,食用n-3 PUFA被认为可降低多种癌症的发生风险,但对肝癌预防作用的专门研究报道甚少。最近美国一项前瞻性研究表明,食用包括鱼类等“白肉”与肝癌呈负相关,但其他研究未发现上述相关性。为此,日本国家癌症中心的Norie Sawada博士及其同事利用上世纪90年代日本卫生部门开展的一项大规模队列研究数据,对90,296例成年人(基线年龄40~69岁)饮食数据进行详细分析,平均随访11年。

受试者完成一份有关上一年138种日常食物摄入的问卷调查,摄入量以标准份量或单位计算。其中19种食物涉及鱼类和贝类,包括咸鱼、干鱼、金枪鱼、鲑鱼或鳟鱼罐头、鲣鱼、金枪鱼、鳕鱼、海鲤鱼、鲭鱼、沙丁鱼、秋刀鱼、鱼子、鳗鱼、鱿鱼、章鱼、虾、蛤、螃蟹、田螺、以及各种鱼酱。研究者根据问卷计算每日鱼类消费量以及n-3 PUFA总摄入量和4种脂肪酸的具体摄入量,并分别计算鲑鱼、鳟鱼、海鲤鱼、鲭鱼、沙丁鱼、秋刀鱼和鳗鱼等富含n-3 PUFA鱼类的摄入量。在常规体检时采集血样,筛查丙型肝炎抗体和乙型肝炎表面抗原,以确定受试者是否携带丙型或乙型肝炎病毒。随访期间共计398例发生HCC。

结果显示,鱼类总摄入量与HCC风险呈弱负相关,最高vs.最低五分位数多变量危险比(HR)为0.64[95%置信区间(CI)为0.4~1.02,P=0.07]。若仅限于富含n-3 PUFA鱼类的摄入,则上述相关性达到统计学显著水平,HR为0.64(95% CI,0.42~0 .96;P=0.04)。HCC风险与EPA、DPA和DHA摄入量呈显著剂量依赖性负相关。校正年龄、性别、吸烟状况和体重指数后,上述相关性仍然存在,并且饮酒者和咖啡饮用者等亚组间也具有上述相关性。乙肝或丙肝阳性患者亚组食用富含n-3 PUFA鱼类与HCC风险也呈高度负相关。

研究者指出,PUFA对肝癌保护作用的机理尚不清楚。鉴于HCC是一种与炎症有关的癌症,肝炎病毒或酒精等毒性化合物暴露可引起慢性炎症,推测PUFA的肝癌保护作用或许与其抗炎作用有关。

该研究的局限性表现为应估算鱼类和各种脂肪酸的摄入量,而不是直接测定其含量。此外,饮食数据仅来自于受试者一个时间点的自我报告。

该研究由日本国家癌症中心研究与开发基金会和厚生省资助。作者报告无相关利益冲突。(生物谷Bioon.com)

doi:10.1053/j.gastro.2012.02.018
PMC:

PMID:

Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma

Norie Sawada, Manami Inoue, Motoki Iwasaki, Shizuka Sasazuki, Taichi Shimazu, Taiki Yamaji, Ribeka Takachi, Yasuhito Tanaka, Masashi Mizokami, Shoichiro Tsugane

Background & Aims

Fish is a rich source of n-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). Although consumption of fish and n-3 PUFA has been reported to protect against the development of some types of cancer, little is known about its association with hepatocellular carcinoma (HCC).

Methods

We investigated the association between fish and n-3 PUFA consumption and HCC incidence (n = 398) in a population-based prospective cohort study of 90,296 Japanese subjects (aged, 45–74 y). Hazard ratios and 95% confidence intervals (CIs) for the highest vs the lowest quintile were estimated from multivariable adjusted Cox proportional hazards regression models. We also conducted subanalyses of subjects with known hepatitis B virus (HBV) or hepatitis C virus (HCV) status, and of subjects who were anti-HCV and/or hepatitis B surface antigen positive. All tests of statistical significance were 2-sided.

Results

Among all subjects, consumption of n-3 PUFA-rich fish and individual n-3 PUFAs was associated inversely with HCC, in a dose-dependent manner. Hazard ratios for the highest vs lowest quintiles were 0.64 (95% CI, 0.42–0.96) for n-3 PUFA-rich fish, 0.56 (95% CI, 0.36–0.85) for EPA, 0.64 (95% CI, 0.41–0.98) for DPA, and 0.56 (95% CI, 0.35–0.87) for DHA. These inverse associations were similar irrespective of HCV or HBV status.

Conclusions

Consumption of n-3 PUFA-rich fish or n-3 PUFAs, particularly EPA, DPA, and DHA, appears to protect against the development of HCC, even among subjects with HBV and/or HCV infection.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061317, encodeId=bffa206131e53, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Aug 04 14:58:00 CST 2012, time=2012-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710604, encodeId=98591e1060418, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sat Apr 20 22:58:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071454, encodeId=836020e1454a6, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Tue Oct 09 05:58:00 CST 2012, time=2012-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063816, encodeId=aa642063816ad, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri Dec 14 07:58:00 CST 2012, time=2012-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504138, encodeId=803515041381d, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat May 26 08:58:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-08-04 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061317, encodeId=bffa206131e53, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Aug 04 14:58:00 CST 2012, time=2012-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710604, encodeId=98591e1060418, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sat Apr 20 22:58:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071454, encodeId=836020e1454a6, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Tue Oct 09 05:58:00 CST 2012, time=2012-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063816, encodeId=aa642063816ad, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri Dec 14 07:58:00 CST 2012, time=2012-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504138, encodeId=803515041381d, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat May 26 08:58:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2061317, encodeId=bffa206131e53, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Aug 04 14:58:00 CST 2012, time=2012-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710604, encodeId=98591e1060418, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sat Apr 20 22:58:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071454, encodeId=836020e1454a6, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Tue Oct 09 05:58:00 CST 2012, time=2012-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063816, encodeId=aa642063816ad, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri Dec 14 07:58:00 CST 2012, time=2012-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504138, encodeId=803515041381d, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat May 26 08:58:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-10-09 许安
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061317, encodeId=bffa206131e53, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Aug 04 14:58:00 CST 2012, time=2012-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710604, encodeId=98591e1060418, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sat Apr 20 22:58:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071454, encodeId=836020e1454a6, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Tue Oct 09 05:58:00 CST 2012, time=2012-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063816, encodeId=aa642063816ad, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri Dec 14 07:58:00 CST 2012, time=2012-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504138, encodeId=803515041381d, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat May 26 08:58:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2061317, encodeId=bffa206131e53, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Aug 04 14:58:00 CST 2012, time=2012-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710604, encodeId=98591e1060418, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Sat Apr 20 22:58:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071454, encodeId=836020e1454a6, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Tue Oct 09 05:58:00 CST 2012, time=2012-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063816, encodeId=aa642063816ad, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Fri Dec 14 07:58:00 CST 2012, time=2012-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504138, encodeId=803515041381d, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat May 26 08:58:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]

相关资讯

Cancer Res:科学家发现驱动恶性肿瘤生长和存在的关键激酶

为了更好地理解恶性肿瘤(肉瘤,sarcomas)的信号通路,近日,来自莫非特癌症研究中心的研究者使用先进的基于蛋白质组学的质谱分析法对一组蛋白质酶的特性进行分析,这组酶在癌症生物学中扮演者重要的开关作用。研究者发现一种酪氨酸激酶可以驱动(driver)恶性肿瘤的生长和生存。相关研究成果刊登在了近日的国际杂志Cancer Research上。 一般的癌症(carcinomas)来源于上皮细胞,

Pediatrics:叶酸或许可以减少儿童罹患某些癌症

含叶酸食品或许可减少最常见的肾细胞癌症类型和一种儿童脑肿瘤癌症类型的发病率,由美国明尼苏达大学博士后研究员Kimberly J. Johnson博士带领完成的一项研究证实了这一观点。 自1998年以来,FDA已责成推广含叶酸食物,因为早先的研究已经表明产前孕妇消耗叶酸的话能显著降低婴儿神经管缺陷的发病率。 Johnson表示:这项研究是迄今为止规模最大的相关研究,研究证实了叶酸也可以降低美国儿

Sci Transl Med:两种药物结合可有效阻止肝癌的发生

近日,来自Bellvitge生物医药研究院的研究者研究发现,两种mTOR蛋白抑制剂结合之后会阻止原发性肝癌的发展并且可以破坏肿瘤细胞,相关研究成果刊登在了近日的国际杂志Science Translational Medicine上。 原发性肝癌或肝细胞癌是世界上第五大常见的癌症,因其强烈的攻击性,是世界上第三大致死性疾病。在世界范围内,该疾病影响着50万人的健康,每三个患者中有两个和慢性酒精中毒

Cancer cell:基底样乳腺癌的新组合治疗策略

多个研究项目包括2006年北卡罗莱纳大学教堂山分校进行的研究已采用DNA芯片分析技术,找出了几个乳腺癌亚型包括管状A型(luminal A)、管状B型,(luminal B)、基底样型和Her-2过度表达型。目前正在开发较简单的测试技术,以帮助医生确定这些亚型。近来,这些测试技术已帮助多项研究证实了基底样或三阴性乳腺癌可能在非裔美国人比白种人更流行更普遍。 UNC莱恩伯格科学家Charles

Science:研究者揭示抑制癌症的新靶点PARP-1

5月11日,刊登在国际著名杂志Science上的一项研究阐明了一种DNA损伤检测酶PARP-1,当这种酶被抑制后,可以有效抵御癌症和其它疾病。来自托马斯杰佛逊大学和杰佛逊金梅尔癌症中心的研究者揭示了新的靶点,包括特殊的锌指结构域,从而来使得特殊药物作用于PARP-1使其丧失活性。研究者希望发现更多副作用较小的特殊PARP-1的抑制子来达到抑制PARP-1的目的,抑制PARP-1的药物目前已证实在治

乳腺癌干细胞研究进展

乳腺癌干细胞的分子特征,图片来自互动百科。 癌症起源于人体内一些发生突变的细胞,而且随后其中一些不断发生突变,导致逃避体内免疫系统的监控,同时不受控制地生长。如今,癌症已经成为人类面临着的一大灾难。更令人讨厌的是,癌症病人经过常规的化疗和放疗治疗之后,常常会复发,而且造成的危害更加严重。鉴于此,科学家们提出癌干细胞是造成癌症转移和复发的根本原因。但是,对于癌干细胞是否存在,科学界一直存在争议。然

Baidu
map
Baidu
map
Baidu
map